European Journal of Life Sciences “EJLS” is published by Anadolu University Faculty of Pharmacy. EJLS is an online peer-reviewed journal following the guidelines provided by the International Committee of Medical Journal Editors (ICMJE) and Committee on Publication Ethics (COPE). All published articles in the EJLS will be assigned with a unique Digital Objective Identifier (DOI) provided by CrossRef and archived by the LOCKSS system, which guarantees long-term digital preservation of the paper.
EJLS is an open-access international journal. It provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. The manuscripts submitted to the EJLS are double-blind peer-reviewed. Submitted manuscripts must not have been previously published elsewhere and not currently be under review by another journal.
Processing and publication are free of charge. EJLS publishes three issues per year (April, August and December) and accepts research articles, review articles, short communications and case reports on all aspects of life sciences. Corresponding authors should submit their manuscripts through the online submission system of Dergipark.
2024 - Volume: 3 Issue: 2
Research Article
Synthesis of Novel Thiazole Derivatives Against Alzheimer's Disease And Investigation Of Their Cholinesterase Inhibition And Antioxidant Properties